Bookmark and Share

Nairobi...vaccine for millions; but none made here

CBC's Carolyn Dunn has some questions about big drug companies exclusively manufacturing a new vaccine for developing countries, leaving out local companies -- even though donations from countries like Canada and prominent global charities provide the financing.

In Nairobi, Carolyn spoke to Helen Evans, CEO of Global Alliance for Vaccines And Immunisation (GAVI) -- which co-ordinated the roll-out of a massive project to eventually vaccinate 600 million children against prominent forms of pneumococcal diseases -- a leading killer of children under five years old in developing countries..

So far only GlaxoSmithKline and Pfizer have the exclusive contract to make the vaccine, and organizations like Doctors Without Borders say many countries could produce it cheaper locally.

  • Commenting has been disabled for this entry.